Skip to main content
. 2014 Mar 5;9(3):e89146. doi: 10.1371/journal.pone.0089146

Figure 1. CFMs reduce viabilities of the human MPM cells.

Figure 1

Cells were treated with vehicle (Untreated Control), indicated doses of Cisplatin, various CFMs, or a combination of Cisplatin and CFMs for 24 h (A) or 48 h (B). Determination of viable/live cells was carried out by MTT assay. The data in the histograms represent means of three independent experiments; bars, S.E. * and #, pā€Š=ā€Š<0.05 relative to Untreated Control (A). Note that the Y-axis scale is different in panel B.